
Conivate-GN Cream by Coniak Lifesciences is a topical combination formulation containing Clotrimazole, Beclomethasone Dipropionate and Neomycin. It combines antifungal, corticosteroid and antibacterial ingredients for selected dermatological conditions when medically appropriate.
Clotrimazole is an imidazole antifungal agent that works by inhibiting ergosterol synthesis, an essential process involved in fungal cell membrane formation. This action helps control the growth of susceptible fungi.
Beclomethasone Dipropionate is a corticosteroid that reduces skin inflammation, redness, swelling and itching by suppressing inflammatory responses.
Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis, helping control certain susceptible bacterial infections.
Conivate-GN Cream may be prescribed for selected skin conditions when the combination of these ingredients is considered appropriate by a qualified healthcare professional. However, corticosteroid-containing combination creams are not recommended for routine treatment of uncomplicated fungal skin infections.
Available in a 15 gm tube, Conivate-GN Cream is intended for external application only. It should be used strictly according to a dermatologist's instructions.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Coniak Lifesciences is a WHO-GMP and ISO 9001:2015 certified pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana, India.
Key Company Details
• Established: 2014
• Headquarters: Plot No. 208, Industrial Area, Phase-1, Panchkula, Haryana, 134113
• Certifications: WHO-GMP and ISO certified
• Phone Number: +91-9570599567
• Official Website: Coniak Lifesciences
Core Operations & Offerings
• Product Formulations: Manufactures and supplies allopathic, herbal, Ayurvedic, and nutraceutical medicines.
• Dosage Forms: Tablets, capsules, softgels, syrups, dry syrups, injections, ointments, protein powders, pediatric drops, and dental solutions.
• Featured Brands: Conipraz LSR, Itrarap 100, Conisure P, Cincred 25, and Coniphage-N.
• Business Model: Offers pan-India PCD pharma franchise opportunities with monopoly rights alongside third-party and contract manufacturing services.
• Investment Range: Franchise partnerships typically require an initial investment ranging from ₹50,000 to ₹1.5 lakh depending on the product range.
Would you like details on their product catalog, monopoly territory availability, or franchise terms?